ArticleCureus2026
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Mimicking Central Nervous System Infection in an Adolescent: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can resemble central nervous system infection in children because fever, headache, vomiting, cerebrospinal fluid pleocytosis, and multifocal brain lesions may coexist. We report a previously healthy 13-year-old boy who developed headache, fever, vomiting, and binocular horizontal diplopia. Examination showed transient exotropia with apparent adduction limitation but no encephalopathy, seizures, limb weakness, pupillary abnormality, optic neuritis, or spinal cord lesion. Cerebrospinal fluid showed mononuclear-predominant pleocytosis with mildly elevated protein. Brain magnetic resonance imaging showed evolving patchy fluid-attenuated inversion recovery hyperintensities in the right temporal lobe, basal ganglia, periventricular region adjacent to the fourth ventricle, and later the right frontal lobe. Extensive microbiological testing was unrevealing. Serum myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) was repeatedly positive by live cell-based assay, whereas aquaporin-4 immunoglobulin G (AQP4-IgG) and autoimmune encephalitis antibodies were negative. Clinical improvement occurred during overlapping treatment with intravenous immunoglobulin and corticosteroids. On illness day 97, during prednisone tapering following an individualized off-label decision to use rituximab, the patient remained clinically stable. This case highlights that pediatric MOGAD should be considered when an infection-like central nervous system presentation is accompanied by evolving multifocal magnetic resonance imaging abnormalities and negative pathogen studies. Diplopia can be an important focal clue; however, because the ocular motor examination was incomplete, internuclear ophthalmoplegia could not be confirmed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.